🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Su Jin Lim

Kim's Eye Hospital

ORCID: 0000-0001-5532-9610
MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 5%percentile
0.459Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

CD137 agonism enhances anti-PD1 induced activation of expanded CD8+ T cell clones in a neoadjuvant pancreatic cancer clinical trial

iScience(2024)10.1016/j.isci.2024.111569
Top 41%
0.459DataRank
Top 41%15 citations

Jacob T. Mitchell, Joseph A. Tandurella, Eric S. Christenson, Ludmila Danilova, Atul Deshpande +29 more

Papers

Driven by 18 papers — median percentile 59. Top paper: “Neoadjuvant enoblituzumab in localized prostate cancer: a single-arm, phase 2 trial”.

Neoadjuvant enoblituzumab in localized prostate cancer: a single-arm, phase 2 trial

Nature Medicine(2023)10.1038/s41591-023-02284-w
N/A
3.0DataRank · unranked
106 citations

Angelo M. De Marzo, Tamara L. Lotan, Hao Wang, Sin Chan, Su Jin Lim +19 more

A platform trial of neoadjuvant and adjuvant antitumor vaccination alone or in combination with PD-1 antagonist and CD137 agonist antibodies in patients with resectable pancreatic adenocarcinoma

Nature Communications(2023)10.1038/s41467-023-39196-9
N/A
1.4DataRank · unranked
87 citations

Carol Judkins, Keyu Li, Su Jin Lim, Jessica Hoare, Rose Parkinson +24 more

Multi-omic analyses of changes in the tumor microenvironment of pancreatic adenocarcinoma following neoadjuvant treatment with anti-PD-1 therapy

Cancer Cell(2022)10.1016/j.ccell.2022.10.001
N/A
0.778DataRank · unranked
178 citations

Joseph A. Tandurella, Jessica Gai, Qingfeng Zhu, Su Jin Lim, Dwayne L. Thomas +26 more

Cell-free DNA Predicts Prolonged Response to Multi-agent Chemotherapy in Pancreatic Ductal Adenocarcinoma

Cancer Research Communications(2022)10.1158/2767-9764.crc-22-0343
N/A
0.722DataRank · unranked
12 citations

Su Jin Lim, Jennifer N. Durham, Ana De Jesus‐Acosta, Katherine M. Bever, Daniel A. Laheru +6 more

Viral status, immune microenvironment and immunological response to checkpoint inhibitors in hepatocellular carcinoma

Journal for ImmunoTherapy of Cancer(2020)10.1136/jitc-2019-000394
N/A
0.624DataRank · unranked
63 citations

Ludmila Danilova, Su Jin Lim, Rohan Verma, Stephanie Xavier, James M. Leatherman +6 more

CD137 agonism enhances anti-PD1 induced activation of expanded CD8+ T cell clones in a neoadjuvant pancreatic cancer clinical trial

iScience(2024)10.1016/j.isci.2024.111569
Top 41%
0.459DataRank
Top 41%15 citations

Jacob T. Mitchell, Joseph A. Tandurella, Eric S. Christenson, Ludmila Danilova, Atul Deshpande +29 more

Neoadjuvant and adjuvant antitumor vaccination alone or combination with PD1 blockade and CD137 agonism in patients with resectable pancreatic adenocarcinoma.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.4_suppl.558
N/A
0.345DataRank · unranked
9 citations

Carol Judkins, Su Jin Lim, Hao Wang, Rose Parkinson, Jessica Gai +15 more

Phase 2 study of olaparib (without ADT) in men with biochemically recurrent prostate cancer (BCR) after prostatectomy.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.5087
N/A
0.241DataRank · unranked
4 citations

Benjamin A. Teply, Su Jin Lim, Hao Wang, Shifeng Mao, William Kevin Kelly +10 more

A phase II randomized trial of Observation versus stereotactic ablative RadiatIon for OLigometastatic prostate CancEr (ORIOLE).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.116
N/A
0DataRank · unranked
2 citations

Ryan Phillips, William T. Shi, Su Jin Lim, Emmanuel S. Antonarakis, Steven P. Rowe +15 more

Tumor Frameshift Mutation Proportion Predicts Response to Immunotherapy in Mismatch Repair-Deficient Prostate Cancer

The Oncologist(2020)10.1002/onco.13601
N/A
0DataRank · unranked
58 citations

Julia Fountain, Pedro Isaacsson Velho, Su Jin Lim, Hao Wang, Emily Nizialek +15 more

Predictive ability of pancreatic cyst fluid biomarkers: A systematic review and meta-analysis

Pancreatology(2023)10.1016/j.pan.2023.05.005
N/A
0DataRank · unranked
74 citations

Kevin T Jamouss, Elham Afghani, Su Jin Lim, Salvador Rodriguez Franco, Harrison Mayo +6 more

A phase I study of a mutant KRAS-targeted long peptide vaccine combined with ipilimumab/nivolumab in resected pancreatic cancer and MMR-proficient metastatic colorectal cancer.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.4_suppl.tps814
N/A
0DataRank · unranked
16 citations

Thatcher Heumann, Maureen Berg, Anna Ferguson, Su Jin Lim, Hao Wang +6 more

A phase I study of a mutant KRAS-targeted long peptide vaccine in patients at high risk of developing pancreatic cancer.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.4_suppl.tps758
N/A
0DataRank · unranked
11 citations

Carol Judkins, Anna Ferguson, Elizabeth Abou Diwan, Su Jin Lim, Hao Wang +7 more

Data from Cell-free DNA Predicts Prolonged Response to Multi-agent Chemotherapy in Pancreatic Ductal Adenocarcinoma

(2023)10.1158/2767-9764.c.6550898.v1
N/A
0DataRank · unranked
0 citations

Su Jin Lim, Jennifer N. Durham, Ana De Jesus‐Acosta, Katherine M. Bever, Daniel A. Laheru +6 more

The impacts of total body irradiation on umbilical cord blood hematopoietic stem cell transplantation

Therapeutic Advances in Hematology(2023)10.1177/20406207231170708
N/A
0DataRank · unranked
0 citations

Kristin Berger, Elizabeth L. Miller, Wei Fu, Larisa Broglie, Frederick D. Goldman +8 more

Quantitation of cancer treatment response by 2-[18F]FDG PET/CT: multi-center assessment of measurement variability using AUTO-PERCIST™

Research Square(2021)10.21203/rs.3.rs-93282/v2
N/A
0DataRank · unranked
0 citations

Su Jin Lim, Hao Wang, Jeffrey P. Leal, Hui‐Kuo G. Shu, Richard L. Wahl +1 more

Tumor Mutational Burden, Toxicity, and Response of Immune Checkpoint Inhibitors Targeting PD(L)1, CTLA-4, and Combination: A Meta-regression Analysis

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-0458
N/A
0DataRank · unranked
109 citations

Su Jin Lim, Aleksandra Popović, Nilofer S. Azad, Daniel A. Laheru, Lei Zheng +4 more

Quantitation of cancer treatment response by 2-[18F]FDG PET/CT: multi-center assessment of measurement variability using AUTO-PERCIST™

EJNMMI Research(2021)10.1186/s13550-021-00754-1
N/A
0DataRank · unranked
7 citations

Joo Hyun O, Su Jin Lim, Hao Wang, Jeffrey P. Leal, Hui‐Kuo G. Shu +2 more